Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
33 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ENDOCRINOLOGIE AZ MARIA MIDDELARES from Gent, company number BE0757534366, closed financial year 2025 with a result of € 1,961 after tax. For that financial year ENDOCRINOLOGIE AZ MARIA MIDDELARES recorded a gross margin of € 203,405 and equity of € 38,561. Compared with financial year 2024, the result moved from € -9,686 to € 1,961. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 38,561
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1,961
▲ still € 9,687 loss in 2024
Profit after tax over the fiscal year.
€ 96,761
▲ 5% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 18,401.
People and assets in 2025
€ 198,110
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 9
▼ 99% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 16,500
▲ 65% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,915
▲ 45% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 168,338 | € 226,502 | € 186,001 | € 203,405 | ▲ 9% |
| Profit after taxes | € 5,057 | € 24,240 | € -9,686 | € 1,961 | ▲ € 11,648 |
| Equity | € 22,046 | € 46,286 | € 36,599 | € 38,561 | ▲ 5% |
| Total debts | € 36,867 | € 58,292 | € 57,794 | € 74,615 | ▲ 29% |
| Cash | € 38,207 | € 97,889 | € 91,718 | € 96,761 | ▲ 5% |
| Retained profit | € 1,886 | € 26,126 | € 16,439 | € 18,401 | ▲ 12% |
| Balance sheet total | € 58,913 | € 104,578 | € 94,393 | € 113,175 | ▲ 20% |
Key figures of ENDOCRINOLOGIE AZ MARIA MIDDELARES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ENDOCRINOLOGIE AZ MARIA MIDDELARES?
What happened at ENDOCRINOLOGIE AZ MARIA MIDDELARES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1,961. Source: NBB ↗
- Amelie Decock became a director. NBB
- Joris Rötgens became a director. NBB
- Valerie Taelman became a director. NBB
- Yuran Vanwonterghem became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Barbara Vandendriessche became a director. NBB
In short
From € 5,057 profit in 2022 to € 1,961 profit in 2025.
Paid € 6,909 in corporate taxes since 2022.
Best year ever: 2023, with € 24,240 profit.
A new publication or filing at ENDOCRINOLOGIE AZ MARIA MIDDELARES? We notify you, reason included.
Follow ENDOCRINOLOGIE AZ MARIA MIDDELARESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ENDOCRINOLOGIE AZ MARIA MIDDELARES are Amelie Decock, Barbara Vandendriessche, Joris Rötgens, Emmanuelle Versele, Valerie Taelman and Yuran Vanwonterghem. Barbara Vandendriessche is also behind Dr. B. Vandendriessche Endocrino.
Directors
According to the 2025 annual accounts
Amelie Decock
Director
since 2026
since 2020
Joris Rötgens
Director
since 2026
Emmanuelle Versele
Director
since 2020
since 2026
since 2026
since 2020
Establishments
Establishment units
Physical locations of this company
Buitenring-Sint-Denijs 30
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 33 companies are registered at this address.
All companies at this address →Maria Middelares
Vereniging der Artsen van Maria Middelares
€ 7.4 million revenue · 2025
Hartcentrum Maria Middelares
Medische Kring van het Algemeen Ziekenhuis Maria Middelares
Associatie neurologie AZ Maria Middelares
+28 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0757.534.366
- VAT number
- BE 0757.534.366
- Registered office
- Buitenring-Sint-Denijs 30, 9000 Gent
- Names & denominations
- ENDOCRINOLOGIE AZ MARIA MIDDELARES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 October 2020
- Peppol
- Active · Active since 2 Jul 2025
- Contact
- [email protected]
- Activities · NACE
Activiteiten van medisch specialisten